The CNIC at the European Society of Cardiology Congress 2026
The Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC) will have a strong presence at the European Society of Cardiology (ESC) Congress 2026, with an extensive scientific programme that includes landmark clinical trials, presentations of basic and translational research, European consensus documents, keynote lectures, roundtable discussions, clinical case sessions, and session chairmanships.
Explore a selection of the CNIC's outstanding contributions here:
Friday, 28 August
- 09:15
- 09:19
Session: Non-conventional risk factors for cardiovascular disease and how to deal with them
Depression and psychosocial adversity: from mechanism to manageable risk factor. Héctor Bueno.
- 10:15
Session: Pulmonary hypertension: pre-clinical.
Empagliflozin attenuates pulmonary vascular hemodynamic progression and improves right ventricular adaptation in overcirculation-induced pulmonary hypertension. Ana García-Álvarez.
- 10:45
Session: Clinical Cases: Non-bacterial endocarditis: complex management decisions illustrated through cases
Chairperson: Carlos Nicolás Pérez García.
- 11:00
Session: Building the next-generation care models in cardio-oncology
Clonal haematopoiesis as a new driver of cardiovascular risk. José Javier Fuster.
- 11:30
Session: Beyond the guidelines: closing outcome gaps in cardiovascular care in ethnically diverse populations
Cardiovascular care for women in different parts of the world: challenges and solutions. María Rubini Giménez.
- 12:00
Session: Clot in transit: pulmonary embolism cases explored
Chairperson: Ana García Álvarez
- 12:30
Session: Fireside Chat: the secrets of successful cardiovascular ageing.
José Javier Fuster
- 12:30
Session: Macrophage biology and inflammation in cardiovascular disease (Abstract Session)
HDL-associated phosphatidylserine modulates the myeloid compartment and protects from atherosclerosis. Aurora Bernal.
Saturday, 29 August
- 08:15
Session: Automated decision-making and new forms of choice: are machine learning and generative models in medicine support or risk tools? (Special Session)
Genomics and genetic testing: variant interpretation, family risk assessment, and reporting standards. Ana García-Álvarez.
Acute cardiovascular care: triage support, risk prediction, and workflow optimisation in emergency settings. María Rubini Giménez.
- 08:45
Symposium: Cardiovascular prevention in 2026: from novel tools to societal impact
Imaging and subclinical atherosclerosis: enabling precision prevention. Valentin Fuster.
- 09:00
Session: REACT - Prevalence of silent atherosclerosis across adult life.
Henning Bundgaard (Rigshospitalet - Copenhagen University Hospital - Copenhagen, Denmark).
- 11:00
Session: The floor is yours: bring your questions on hormonal replacement therapy and cardiovascular health.
Chairperson: María Rubini Giménez.
- 13:45
Session: Cutting-edge science in dilated cardiomyopathy
Chairperson: Pablo García-Pavía.
- 14:30
Session: Clinical Cases: Cases of prosthetic valve endocarditis: learning from experience.
Chairperson: Carlos Nicolás Pérez García.
- 16:45
Session: Artificial intelligence tools in clinical trials and precision medicine.
Automating data extraction from discharge reports via multimodal LLMs in the REBOOT trial. Fátima Sánchez Cabo.
- 17:00
Session: Pulmonary hypertension in the real world
Chairperson: Ana García-Álvarez.
Sunday, 30 August
- 08:15
Session: Illustrative cases of cardiovascular disease in women (Clinical Cases)
Chairperson: María Rubini Giménez.
- 11:00
Session: Joint session with the Asian Pacific Society of Cardiology (APSC).
Artificial intelligence for integration of multiomics in post-acute coronary syndrome patients. Fátima Sánchez Cabo.
- 12:00
Session: Young Investigator Award Session in Cardiovascular Disease in Women
Chairperson: María Rubini Giménez.
- 12:30
Session: Fireside Chat: fireside with the legends
Fireside Chat: fireside with the legends. Valentin Fuster.
- 13:45
Session: Preventing heart failure
State-of-the-art lecture on preventing heart failure. Borja Ibáñez.
- 13:45
Session: Late-Breaking Clinical Science: cardiac amyloidosis
Efficacy and safety of transthyretin gene silencer eplontersen in patients with transthyretin amyloid cardiomyopathy receiving stabiliser therapy in the CARDIO-TTRansform trial. Pablo García Pavía.
- 16:15
Session: Cardiovascular prevention in children and adolescents.
Tools for primordial prevention of cardiovascular disease. Valentin Fuster.
- 17:15
Session: Ischaemia-reperfusion injury: new biological mechanisms of repair
Chairperson: Carlos Galán.
- 18:30
ESC Working Groups and Councils Awards & Networking Reception
José Javier Fuster: ESC Outstanding Achievement Award.
Monday, 31 August
- 11:11
Session: Made Easy Series – Solving the well-being crisis in healthcare professionals
How to build work-life integration. María Rubini Giménez.
- 11:15
Session: Great Debate: no more beta-blockers for post-myocardial infarction patients with preserved left ventricular ejection fraction
No more beta-blockers for post-myocardial infarction patients with preserved left ventricular ejection fraction: pro: Borja Ibáñez.
- 13:15
Session: Improving understanding of disease in dilated cardiomyopathy (Moderated ePosters)
Chairperson: Enrique Lara-Pezzi.
